Consolidated Statement of Cash Flows (Unaudited) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Operating activities
Net increase/(decrease) in net assets resulting from operations	$ 3,075
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(574)
Net change in unrealized (gain) loss on investments	1,959
Payments to purchase investments	(261,564)
Proceeds from sale of investments	46,722
Net (increase) decrease on derivatives	(10,530)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(5,451)
(Increase)/decrease in deferred offering expenses	(1,436)
(Increase)/decrease in interest receivable	(1,354)
(Increase)/decrease in receivable for investments sold	(16)
(Increase)/decrease in prepaid expenses and other assets	(3,390)
Increase/(decrease) in due to Operating Manager	7,338
Increase/(decrease) in payable for investments purchased	4,845
Increase/(decrease) in performance fees payable	12
Increase/(decrease) in interest payable	10
Increase/(decrease) in offering expenses payable	(1,350)
Increase/(decrease) in organizational expenses payable	(628)
Increase/(decrease) in other accrued expenses and liabilities	1,330
Net cash provided by (used in) operating activities	(221,002)
Financing activities
Notes Borrowings	1,502
Proceeds from issuance of shares (net of change in capital subscriptions receivable)	278,085
Net cash provided by (used in) financing activities	279,587
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	58,585
Cash and cash equivalents at beginning of year	2
Cash and cash equivalents at end of year	58,587
Supplemental disclosure of cash flow information:
Income taxes paid	338
Cash paid for interest	68
Series I
Operating activities
Net increase/(decrease) in net assets resulting from operations	467
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(136)
Net change in unrealized (gain) loss on investments	675
Payments to purchase investments	(76,146)
Proceeds from sale of investments	13,552
Net (increase) decrease on derivatives	(3,061)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(1,453)
(Increase)/decrease in deferred offering expenses	(135)
(Increase)/decrease in interest receivable	(406)
(Increase)/decrease in receivable for investments sold	(5)
(Increase)/decrease in prepaid expenses and other assets	(1,026)
Increase/(decrease) in due to Operating Manager	2,133
Increase/(decrease) in payable for investments purchased	1,409
Increase/(decrease) in performance fees payable	12
Increase/(decrease) in interest payable	5
Increase/(decrease) in offering expenses payable	(675)
Increase/(decrease) in organizational expenses payable	(314)
Increase/(decrease) in other accrued expenses and liabilities	427
Net cash provided by (used in) operating activities	(64,677)
Financing activities
Notes Borrowings	751
Proceeds from issuance of shares (net of change in capital subscriptions receivable)	80,742
Net cash provided by (used in) financing activities	81,493
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	16,816
Cash and cash equivalents at beginning of year	1
Cash and cash equivalents at end of year	16,817
Supplemental disclosure of cash flow information:
Income taxes paid	88
Cash paid for interest	34
Series II
Operating activities
Net increase/(decrease) in net assets resulting from operations	2,608
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(438)
Net change in unrealized (gain) loss on investments	1,284
Payments to purchase investments	(185,418)
Proceeds from sale of investments	33,170
Net (increase) decrease on derivatives	(7,469)
Changes in operating assets and liabilities:
(Increase)/decrease in due from Operating Manager	(3,998)
(Increase)/decrease in deferred offering expenses	(1,301)
(Increase)/decrease in interest receivable	(948)
(Increase)/decrease in receivable for investments sold	(11)
(Increase)/decrease in prepaid expenses and other assets	(2,364)
Increase/(decrease) in due to Operating Manager	5,205
Increase/(decrease) in payable for investments purchased	3,436
Increase/(decrease) in performance fees payable	0
Increase/(decrease) in interest payable	5
Increase/(decrease) in offering expenses payable	(675)
Increase/(decrease) in organizational expenses payable	(314)
Increase/(decrease) in other accrued expenses and liabilities	903
Net cash provided by (used in) operating activities	(156,325)
Financing activities
Notes Borrowings	751
Proceeds from issuance of shares (net of change in capital subscriptions receivable)	197,343
Net cash provided by (used in) financing activities	198,094
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	41,769
Cash and cash equivalents at beginning of year	1
Cash and cash equivalents at end of year	41,770
Supplemental disclosure of cash flow information:
Income taxes paid	250
Cash paid for interest	$ 34